Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid

Metabolomics based on mass spectrometry represents an innovative approach to characterize multifactorial diseases, such as multiple sclerosis (MuS). To date, the most important biomarker source for MuS diagnosis is the cerebrospinal fluid. However, an important goal for research is to identify new m...

Full description

Bibliographic Details
Main Authors: Ilaria Cicalini, Claudia Rossi, Damiana Pieragostino, Luca Agnifili, Leonardo Mastropasqua, Maria di Ioia, Giovanna De Luca, Marco Onofrj, Luca Federici, Piero Del Boccio
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/20/6/1265
id doaj-471a9a773194479ba629adb762284237
record_format Article
spelling doaj-471a9a773194479ba629adb7622842372020-11-24T21:15:56ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-03-01206126510.3390/ijms20061265ijms20061265Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal FluidIlaria Cicalini0Claudia Rossi1Damiana Pieragostino2Luca Agnifili3Leonardo Mastropasqua4Maria di Ioia5Giovanna De Luca6Marco Onofrj7Luca Federici8Piero Del Boccio9Department of Pharmacy, University ‘‘G. d’Annunzio’’ of Chieti-Pescara, 66100 Chieti, ItalyAnalytical Biochemistry and Proteomics Laboratory, Centre on Aging Sciences and Translational Medicine (Ce.S.I-MeT), University ‘‘G. d’Annunzio’’ of Chieti-Pescara, 66100 Chieti, ItalyAnalytical Biochemistry and Proteomics Laboratory, Centre on Aging Sciences and Translational Medicine (Ce.S.I-MeT), University ‘‘G. d’Annunzio’’ of Chieti-Pescara, 66100 Chieti, ItalyOpthalmic Clinic, Department of Medicine and Aging Science, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyOpthalmic Clinic, Department of Medicine and Aging Science, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyUnit of Neurology Ss Annunziata Hospital, 66100 Chieti, ItalyUnit of Neurology Ss Annunziata Hospital, 66100 Chieti, ItalyUnit of Neurology Ss Annunziata Hospital, 66100 Chieti, ItalyAnalytical Biochemistry and Proteomics Laboratory, Centre on Aging Sciences and Translational Medicine (Ce.S.I-MeT), University ‘‘G. d’Annunzio’’ of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Pharmacy, University ‘‘G. d’Annunzio’’ of Chieti-Pescara, 66100 Chieti, ItalyMetabolomics based on mass spectrometry represents an innovative approach to characterize multifactorial diseases, such as multiple sclerosis (MuS). To date, the most important biomarker source for MuS diagnosis is the cerebrospinal fluid. However, an important goal for research is to identify new molecules in more easily accessible biological fluids. A very interesting biofluid in MuS is represented by tears, considered as an intermediate fluid between the cerebrospinal fluid and serum. In this work, we developed a merged strategy for the analysis of lipids containing choline by Liquid Chromatography coupled to Tandem Mass Spectrometry (LC-MS/MS), as well as for the targeted analysis of free carnitine, acylcarnitines and aminoacids by direct infusion mass spectrometry. Samples for both metabolomics and lipidomics approaches were obtained in a single extraction procedure from tears of patients affected by MuS and healthy controls. Tear lipidomics showed 30 phospholipids significantly modulated and, notably, many sphingomyelins resulted lower in MuS. Moreover, the metabolomics approach carried out both on tears and serum highlighted the diagnostic potential of specific aminoacids and acylcarnitines. In conclusion, the metabolic profiling of tears appears to reflect the pathological conditions of the central nervous system, suggesting that the molecular repository of tears can be considered as a source of potential biomarkers for MuS.http://www.mdpi.com/1422-0067/20/6/1265metabolomicslipidomicstearsbiomarkersamino acidsacylcarnitinesmultiple sclerosis
collection DOAJ
language English
format Article
sources DOAJ
author Ilaria Cicalini
Claudia Rossi
Damiana Pieragostino
Luca Agnifili
Leonardo Mastropasqua
Maria di Ioia
Giovanna De Luca
Marco Onofrj
Luca Federici
Piero Del Boccio
spellingShingle Ilaria Cicalini
Claudia Rossi
Damiana Pieragostino
Luca Agnifili
Leonardo Mastropasqua
Maria di Ioia
Giovanna De Luca
Marco Onofrj
Luca Federici
Piero Del Boccio
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid
International Journal of Molecular Sciences
metabolomics
lipidomics
tears
biomarkers
amino acids
acylcarnitines
multiple sclerosis
author_facet Ilaria Cicalini
Claudia Rossi
Damiana Pieragostino
Luca Agnifili
Leonardo Mastropasqua
Maria di Ioia
Giovanna De Luca
Marco Onofrj
Luca Federici
Piero Del Boccio
author_sort Ilaria Cicalini
title Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid
title_short Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid
title_full Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid
title_fullStr Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid
title_full_unstemmed Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid
title_sort integrated lipidomics and metabolomics analysis of tears in multiple sclerosis: an insight into diagnostic potential of lacrimal fluid
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2019-03-01
description Metabolomics based on mass spectrometry represents an innovative approach to characterize multifactorial diseases, such as multiple sclerosis (MuS). To date, the most important biomarker source for MuS diagnosis is the cerebrospinal fluid. However, an important goal for research is to identify new molecules in more easily accessible biological fluids. A very interesting biofluid in MuS is represented by tears, considered as an intermediate fluid between the cerebrospinal fluid and serum. In this work, we developed a merged strategy for the analysis of lipids containing choline by Liquid Chromatography coupled to Tandem Mass Spectrometry (LC-MS/MS), as well as for the targeted analysis of free carnitine, acylcarnitines and aminoacids by direct infusion mass spectrometry. Samples for both metabolomics and lipidomics approaches were obtained in a single extraction procedure from tears of patients affected by MuS and healthy controls. Tear lipidomics showed 30 phospholipids significantly modulated and, notably, many sphingomyelins resulted lower in MuS. Moreover, the metabolomics approach carried out both on tears and serum highlighted the diagnostic potential of specific aminoacids and acylcarnitines. In conclusion, the metabolic profiling of tears appears to reflect the pathological conditions of the central nervous system, suggesting that the molecular repository of tears can be considered as a source of potential biomarkers for MuS.
topic metabolomics
lipidomics
tears
biomarkers
amino acids
acylcarnitines
multiple sclerosis
url http://www.mdpi.com/1422-0067/20/6/1265
work_keys_str_mv AT ilariacicalini integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid
AT claudiarossi integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid
AT damianapieragostino integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid
AT lucaagnifili integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid
AT leonardomastropasqua integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid
AT mariadiioia integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid
AT giovannadeluca integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid
AT marcoonofrj integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid
AT lucafederici integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid
AT pierodelboccio integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid
_version_ 1716744100238065664